Marizyme (MRZM) 10-Q/A2021 Q2 Quarterly report (amended)

Filed: 22 Nov 21, 1:25pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: abandoned, accrete, accretion, advertising, Africa, Amy, angioplasty, antidilution, arrangement, automatic, automatically, bacterial, bankruptcy, behavior, beneficial, bifurcation, CAGR, calendar, cancelling, Carlo, cast, Chair, Chandler, chose, Columbia, comparison, conclusion, counterparty, Cyto, cytoprotective, daily, deposit, diminishing, disaggregation, dividend, Donald, East, economy, efficacy, embedded, endarterectomy, evolving, exceeded, experienced, expiration, extent, FDIC, feet, force, forecasted, Grand, Hearl, HLII, Hong, idata, immaterial, Insufficient, intervention, Kampf, lattice, lesser, letter, Logic, marketplace, maximize, maximum, medium, methodology, Monte, negatively, NEX, novo, oral, overestimated, owner, pediatric, pertinent, pro, prolong, promote, promoted, provisional, put, Quality, rare, rata, repay, reserve, revalued, Roger, rollout, Saperstein, Schaller, Seller, sharp, shutdown, simulation, SIP, sixty, size, skin, slower, solid, Spain, spending, spread, square, Steven, submission, substance, suffer, Supreme, terminated, termination, thrombectomy, travel, TSX, Turkey, unaffiliated, undefined, unmet, unobservable, unpaid, upcoming, vary, vice, View, voucher, waived, warehouse, William, workforce

Removed: behalf, Canada, center, component, determining, dual, exercisable, exercised, expertise, instance, investor, lead, lieu, measuring, member, merger, network, permit, receive, registration, reliance, reverse, serve, served, short, subscription, subsequently, team, tested, typically

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

MRZM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION OF

PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

§ 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Marizyme, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David Barthel, Chief Executive Officer of the Company, do hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, based on my knowledge, that:

1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	November 22, 2021

By:	/s/ David Barthel
Name:	David Barthel
Title:	Chief Executive Officer

This certification accompanies the Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.